Bernhard Witzenbichler

Showing 1-13 of 13 articles

Coronary interventions

Safety and Efficacy of Ticagrelor Monotherapy According to Drug-Eluting Stent Type: The TWILIGHT-STENT Study

Baber U, Sharma S, Giustino G, Sartori S, Nicolas J, Goel R, Mehta S, Cohen D, Angiolillo D, Zhang Z, Camaj A, Cao D, Briguori C, Dudek D, Escaned J, Huber K, Collier T, Kornowski R, Kunadian V, Moliterno DJ, Ohman EM, Weisz G, Gil R, Krucoff M, Kaul U, Oldroyd K, Sardella G, Shlofmitz R, Witzenbichler B, Kastrati A, Han Y, Steg P, Pocock S, Gibson CM, Mehran R

August 26, 2021 | 10.4244/EIJ-D-21-00721

Coronary interventions

BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months

Saito S, Toelg R, Witzenbichler B, Haude M, Masotti M, Salmeron R, Witkowski A, Uematsu M, Takahashi A, Waksman R, Slagboom T

December 6, 2019 | 10.4244/EIJ-D-18-01214

Derivation and external validation of a novel risk score for prediction of 30-day mortality after percutaneous coronary intervention

Brener S, Leon M, Serruys P, Smits P, von Birgelen C, Mehran R, Kirtane A, Witzenbichler B, Rinaldi M, Metzger C, Mazzaferri E, Zhang Z, Stone G

August 9, 2019 | 10.4244/EIJ-D-19-00262

Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study

Nakatani S, Onuma Y, Ishibashi Y, Karanasos A, Regar E, Garcia-Garcia H, Tamburino C, Fajadet J, Vrolix M, Witzenbichler B, Eeckhout E, Spaulding C, Reczuch K, La Manna A, Spaargaren R, Capodanno D, van Langenhove G, Verheye S, Serruys P, van Geuns R

December 20, 2015 | 10.4244/EIJY15M11_01

Coronary artery treatment with paclitaxel-coated balloon using a BTHC excipient: clinical results of the international real-world DELUX registry

Toelg R, Merkely B, Erglis A, Hoffmann S, Bruno H, Kornowski R, Slagboom T, Naber C, Witzenbichler B, Graf K, Richardt G, Hehrlein C

September 28, 2014 | 10.4244/EIJV10I5A102

Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial

Caixeta A, Lansky A, Mehran R, Brener S, Claessen B, Généreux P, Palmerini T, Witzenbichler B, Guagliumi G, Brodie B, Dudek D, Fahy M, Dangas G, Stone G

June 28, 2013 | 10.4244/EIJV9I2A37

Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial

Rakowski T, Dudek D, Dziewierz A, Yu J, Witzenbichler B, Guagliumi G, Kornowski R, Hartmann F, Lansky A, Brener S, Mehran R, Stone G

March 22, 2013 | 10.4244/EIJV8I11A199

Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial

Tobbia P, Brodie B, Witzenbichler B, Metzger C, Guagliumi G, Yu J, Kellett M, Stuckey T, Fahy M, Mehran R, Stone G

February 22, 2013 | 10.4244/EIJV8I10A176

Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial

Généreux P, Mehran R, Palmerini T, Caixeta A, Kirtane A, Lansky A, Brodie B, Witzenbichler B, Mockel M, Guagliumi G, Peruga J, Dudek D, Fahy M, Dangas G, Stone G

December 30, 2011 | 10.4244/EIJV7I8A144

Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions

Verheye S, Ramcharitar S, Grube E, Schofer J, Witzenbichler B, Kovac J, Hauptmann K-E, Agostoni P, Wiemer M, Lefèvre T, Spaargaren R, Serruys P, Garcia-Garcia H, van Geuns R

September 30, 2011 | 10.4244/EIJV7I5A94

Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: the EUROSTAR-II randomised clinical trial

Silber S, Gutiérrez-Chico J-L, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Naber C, Chevalier B, Serruys P

May 17, 2011 | 10.4244/EIJV7I1A13

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

Serruys P, Garg S, Abizaid A, Ormiston J, Windecker S, Verheye S, Dubois C, Stewart J, Hauptmann K, Schofer J, Stangl K, Witzenbichler B, Wiemer M, Barbato E, de Vries T, Drijver A-M, Otake H, Meredith L, Toyloy S, Fitzgerald P

June 30, 2010

First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days results

Verheye S, Grube E, Ramcharitar S, Schofer J, Witzenbichler B, Kovac J, Hauptmann K-E, Agostoni P, Wiemer M, Lefèvre T, Serruys P, van Geuns R

March 20, 2009

1

Latest news

STATE OF THE ART

Transcatheter treatment for tricuspid valve disease

This State-of-the-Art - by F. Praz et al - reviews the available transcatheter therapies, main criteria for patient and device selection, remaining uncertainties, and future directions

November 19, 2021

PCR London Valves Edition: state of the art on transcatheter treatment for tricuspid valve disease, a mini focus on TR; coronary access after TAVI and more…

November 19, 2021

EuroIntervention is now on Instagram

November 29, 2021

Long-term impact of OCT-assessed suboptimal stent deployment

Francesco Prati et al.

November 25, 2021

Percutaneous tricuspid valve annuloplasty: additional data and remaining questions

Nicole Karam et al.

November 23, 2021

Bioprosthetic valve fracture: haemodynamically effective but safe and clinically necessary?

Josep Rodés-Cabau et al.

November 23, 2021

Guidelines, consensus & position papers

consult the most recent published guidelines, consensus and position papers

November 29, 2021

Valvular disease